Thursday, November 21, 2024
11/21/2024
Center Point, Inc. (CPI) is requesting $522,195 per year for up to five years from the SAMHSA CSAT to implement and expand the delivery of combined buprenorphine-naloxone and other FDA-approved Medication Assisted Treatment, including methadone, in combination with integrated primary care and behavioral health, treatment for substance use and mental health disorders (SUD), case management, care coordination and aftercare services for persons with an opioid disorder (OUD). Project activities will take place in Marin County, CA, and the catchment area will include Marin, Napa, Alameda, and Contra Costa counties. The primary target population will be low-income adult men and women with an OUD and/or co-occurring mental health disorder who 1) are high-risk IV drug users and/or prescription opioid users and, 2) who are clients of CPI's adult residential, outpatient and/or intensive outpatient substance use and mental health disorder treatment programs. CPI's project will increase access to MAT services and lead to a decrease in illicit opioid drug use and prescription opioid misuse for 50 unduplicated individually annually and 250 over the entire project period. CPI will provide MAT within a comprehensive, integrated SUD treatment and recovery support system that includes residential, outpatient, continuing and aftercare, Recovery Residence housing, and vocational and employment services. MAT Project services will be coordinated with psychosocial therapies and recovery supports, and clients will be directly linked into ongoing MAT and primary care in partnership with local Federally Qualified Health Centers (FQHC) and Opioid Treatment Program (OTP). The treatment and service plans that result from this project will be implemented and monitored by certified counselors, medical and mental health clinicians, and case managers acting within their scope of practice. CPI's programs will utilize evidence-based practices including providing integrated services so that MAT, substance use and mental health disorders, and trauma and abuse can be treated in the most effective manner. CPI is a CARF Accredited DHCS licensed and certified program with DHCS-approved ASAM Levels of Care 3.1, 3.2 Withdrawal Management, and 3.5; 1.0 and 2.1 outpatient programs, and is a Drug Medi-Cal Certified provider. Over the five-year grant period, CPI will provide on-site MAT service for 250 people with OUD enrolled in residential, outpatient and/or intensive outpatient substance use disorder treatment; enhance CPI's comprehensive, multi-modality treatment model to accomplish positive outcome for adults with OUD; and enhance CPI's service delivery model to improve substance use and mental health services and coordinate services necessary for MAT patients to achieve and sustain recovery. Outcomes for participants will include increased MAT access and participation, decreased substance abuse, decreased criminal justice system involvement, and overall improvements in emotional and mental health.
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).
